An observational study in Hearing Loss in Children With Unilateral or Bilateral Cochlear Implants, sponsored by Assistance Publique - Hôpitaux de Paris. Recruiting at 1 site in France. Open to participants aged 0 Days to 7 Years. Per ClinicalTrials.gov, last updated 2026-08-10.
Sponsored by Assistance Publique - Hôpitaux de Paris · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Hearing Loss by Assistance Publique - Hôpitaux de Paris — 7 open to participants now, 7 under way, none of them phase 3. Hearing Loss · Assistance Publique - Hôpitaux de Paris.
Among the 13 studies in Hearing Loss by Assistance Publique - Hôpitaux de Paris, this one is the 9th largest by planned enrollment of the 10 observational ones that give a count, is the only one that started in 2026, is one of 10 observational ones, and was the 13th registered.
797 studies on the registry are indexed under Hearing Loss; 194 are open to participants now.
Browse Hearing Loss studies →7 of the 13 studies in Hearing Loss by Assistance Publique - Hôpitaux de Paris are open now, in 1 country. Recruiting first, the newest first:
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 1 days–2 yrs
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 6–16
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18+
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 8–17
Assistance Publique - Hôpitaux de Paris · Sites in France
Ages 18+
By country, each count listing its studies:
Of the 125 Hearing Loss studies recruiting now, 60 (48%) set no upper age limit and 43 (34%) stop at 75 or younger; 47 take children under 18; 46 take healthy volunteers.
This study: 0 Days to 7 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2007; this study’s year is marked. 1 started in 2026.
This study's planned enrollment of 48 is below the median of 100 across 192 observational studies indexed under Hearing Loss.
Median enrollment 69 across the 3 interventional studies, 112 across the 10 observational. Of the 4 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,598 studies on the registry; 1,038 are open to participants now.
2 of the studies in Hearing Loss by Assistance Publique - Hôpitaux de Paris that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06400992Assistance Publique - Hôpitaux de ParisInvestigation of Sky Automatic Technologies in Pediatrics | 2026-12-11 |
| NCT05946577Assistance Publique - Hôpitaux de ParisAssociation Between Tinnitus and Hearing Loss in Locally Advanced Head and Neck Cancer Treated by Radiotherapy Alone or With Chemotherapy: a Prospective and Multicenter Study | 2027-07-09 |
Add all 2 to your calendar (.ics) → With an account.
Among the 13 studies in Hearing Loss by Assistance Publique - Hôpitaux de Paris, from their registry updates:
This tab as a report to print or save as PDF → With an account.
In children aged 0 to 7 years, behavioral evaluation during cochlear implant programming is often difficult or unreliable. Objective, reproducible, and rapid markers are therefore essential. While objective measures such as ECAP (electrically evoked compound action potentials) help guide safe programming, they can show inter-electrode and inter-subject variability. Electrically evoked stapedius reflex threshold (eSRT) has emerged as a relevant objective marker to approximate the comfort level of stimulation.
Pediatric studies indicate that eSRT can be measured in the majority of children, closely corresponds to the comfort level, and is associated with improved speech outcomes when programming is guided by eSRT. In our previous single-center study in children aged 8 to 17 years (N=30; 44 implanted ears), eSRT was obtained in 83.3% of patients, with strong correlation between C-subjective and C-eSRT thresholds (r>0.94; p\<0.001) across all electrodes. Tonal performance remained stable, and speech intelligibility, particularly in noise (FraSiMat), significantly improved with an eSRT-based program after one month of habituation. Daily device use remained stable, reflecting good clinical acceptability. These results support the relevance of systematic integration of eSRT in routine programming.
The aim of the eSRT2 study is to evaluate the feasibility and reliability of eSRT measurement in real-world clinical care for children aged 0 to 7 years, and to monitor its stability during post-operative follow-up. Improved auditory accessibility and better-controlled acoustic comfort through eSRT are expected to accelerate speech development in children by enabling earlier improvements in vocal performance and intelligibility.
Cochlear implant programming relies on determining the patient's auditory dynamic range. This corresponds to identifying, for each electrode, the threshold of first perception (T-level) and the most comfortable level of stimulation (C-level or MCL), which defines the functional stimulation range. Different implant manufacturers (Advanced Bionics, Cochlear, Med-El, Oticon Medical) provide specific recommendations for estimating these upper stimulation levels.
Programming can be performed using behavioral measures or objective measures. Behavioral methods, based on patient responses, are widely used in adults. In children and in patients with associated pathologies, behavioral measures are often difficult due to limited auditory experience and potential confusion between loudness and pitch perception.
Therefore, objective measures are recommended in pediatric populations to assist in programming. ECAP/EAP measures are commonly used but show variable performance depending on the measure and implant manufacturer
Another objective measure, the electrically evoked stapedius reflex threshold (eSRT), shows a strong relationship with comfort levels (C-level/MCL) in both adults and children. eSRT appears to be a relevant tool for guiding programming, especially when subjective measures are limited. Recent studies have optimized the protocol (probe frequencies, reproducibility criteria) and confirmed its feasibility , including in pediatric populations using high-frequency probes (Palani et al., 2022) and normative data in children (Aini, 2022). Combined approaches using ECAP and eSRT to estimate C-levels/MCL are also emerging in pediatric programming .
Functionally, better estimation of the comfort level improves auditory accessibility, which is associated with enhanced speech perception and vocal performance. Over the long term, this supports faster language development in children implanted early.
Our previous eSRT study in children over 8 years old demonstrated a strong correlation between C-subjective and C-eSRT thresholds, and improved speech intelligibility (particularly in noise, FraSiMat) with eSRT-guided maps. These findings support the integration of eSRT into routine programming for pediatric populations.
The target population is pediatric children aged 0 to 7 years followed at a specialized center (Necker Hospital, Paris). In children under 7, cooperation with behavioral testing is often limited, making the use of robust objective markers crucial (Gordon et al., 2004).
Pediatric data suggest that eSRT can be measured in the majority of children and corresponds closely to the C-level (Lorens et al., 2004; Bresnihan et al., 2001; Aini, 2022), with recently optimized protocols (Palani et al., 2022; Wolfe et al., 2017).
The study includes children with unilateral or bilateral cochlear implants, across all implant manufacturers, reflecting real-world practice.
Exclusion of children with unstable middle ear pathology reduces the risk of false-negative eSRT results related to tympano-ossicular transmission.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
All enrolled children (0-7 years) with unilateral or bilateral cochlear implants will undergo electrically evoked stapedius reflex threshold (eSRT) measurements during routine post-operative programming sessions at 3, 6, and 12 months. The eSRT measurement is complementary to standard programming procedures and does not replace any routine clinical care.
Other: Electrically Evoked Stapedius Reflex Threshold (eSRT) Measurement
During routine post-operative programming sessions (at 3, 6, and 12 months), each child will undergo eSRT measurement using a tympanometer placed in the ear canal
To study the stability of eSRT over time at 3, 6, and 12 months: quantifying intra-subject / intra-ear stability of eSRT thresholds throughout follow-up
Success (per session) is defined as obtaining at least 3 usable eSRT measurements distributed across apex, middle, and base (≥1 electrode per third of the array), with a normal tympanogram and meeting the reproducibility criterion (≤5 machine units \[MU\] variation between two attempts on the same electrode).
Time frame: 3, 6, and 12 months post-implantation
To study the stability of eSRT over time at 3, 6, and 12 months: quantifying intra-subject/intra-ear stability of eSRT thresholds throughout follow-up
The variability of eSRT values must be \< 5 machine units (MU) between each pair of visits (3↔6, 6↔12, and 3↔12 months).
Time frame: 3, 6, and 12 months post-implantation
To study the correlation between CeSRT and free-field tonal thresholds; association with speech performance (pediatric lists: Boorsmaa <4 years; Lafon ≥4 years - adjusted to the child's abilities; at the audiologist's discretion)
Correlation between CeSRT and free-field tonal thresholds will be evaluated. Associations with speech performance will be assessed using pediatric lists: Boorsmaa for children \<4 years and Lafon for children ≥4 years, adjusted to the child's abilities and at the audiologist's discretion.
Time frame: 3, 6, and 12 months post-implantation
To document the burden of integrating eSRT into routine clinical practice
eSRT measurement time will be recorded from probe placement to the last usable measurement. Success and failure rates per session will be documented, along with the types of failure causes (non-cooperative child, artifacts, middle ear pathology, equipment/logistics issues).
Time frame: 3, 6, and 12 months post-implantation
Started Jun 2026 (actual). Primary completion is estimated for Jun 2029, 36 months after the start.
Of 77 non-industry observational studies under Hearing Loss, half reached primary completion within 50 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 179. This study's planned 36 months is below that.
Counting every sponsor, half of 99 studies reached it within 42 months; a quarter within 15 and three quarters within 83.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Assistance Publique - Hôpitaux de Paris →